Finance

Lists
NECLIFE:NSE
Nectar Lifesciences Ltd
10,29 INR
+1,28%
(+0,13) 1D
15-окт., 09:52:05 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NECLIFE...
Open
10,10 INR
High
10,30 INR
Low
10,10 INR
Mkt. cap
2,00 млд
Avg. vol.
158,02 миң
Volume
4,83 миң
52-wk high
22,40 INR
52-wk low
9,30 INR
EPS
-11,38 INR
Shares outstanding
224,26 млн
No. of employees
111
Open
10,10 INR
High
10,30 INR
Low
10,10 INR
Mkt. cap
2,00 млд
Avg. vol.
158,02 миң
Volume
4,83 миң
52-wk high
22,40 INR
52-wk low
9,30 INR
EPS
-11,38 INR
Shares outstanding
224,26 млн
No. of employees
111
News stories
From web sources and news partners
About Nectar Lifesciences Ltd
CEO-
Employees111
Founded1995
HeadquartersChandigarh, Chandigarh, Индия
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
49,97 млн
-
-
145,00 миң
Cost of goods sold
33,54 млн
-
-
137,00 миң
Cost of revenue
33,54 млн
-
-
137,00 миң
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,52 млн
6,10 млн
22,94 млн
10,64 млн
Operating expense
21,48 млн
13,26 млн
1,11 млд
244,63 млн
Total operating expenses
55,03 млн
13,26 млн
1,11 млд
244,77 млн
Operating income
-5,06 млн
-13,26 млн
-1,11 млд
-244,63 млн
Other non operating income
-
-
2,40 млн
-
EBT including unusual items
-5,06 млн
566,01 млн
-1,45 млд
-246,20 млн
EBT excluding unusual items
-5,06 млн
-315,50 млн
-1,09 млд
-246,20 млн
Income tax expense
-1,77 млн
-110,25 млн
-197,17 млн
-89,01 млн
Effective tax rate
34,95%
-19,48%
13,59%
36,15%
Other operating expenses
11,92 млн
6,54 млн
1,08 млд
232,89 млн
Net income
-1,76 млд
142,70 млн
-679,24 млн
-153,98 млн
Net profit margin
-3 522,51%
-
-
-106 191,03%
Earnings per share
-
-
-
-
Interest and investment income
-
-
371,18 млн
-
Interest expense
-
-302,25 млн
-
-1,57 млн
Net interest expenses
-
-302,25 млн
371,18 млн
-1,57 млн
Depreciation and amortization charges
2,04 млн
619,00 миң
832,00 миң
1,11 млн
EBITDA
104,86 млн
142,71 млн
-1,05 млд
-187,62 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору